DHEA (Dehydroepiandrosterone; Prasterone) Powder CAS 53-43-0
| Product Name |
Dehydroepiandrosterone |
| CAS |
53-43-0 |
| Purity |
99% |
| Molecular Formula |
C19H28O2 |
| Molecular Weight |
288.43 |
| EINECS |
200-175-5 |
| Density |
1.12 g/cm3 |
| Boiling Point |
426.7 °C at 760 mmHg |
| Appearance |
white fine crystalline powder |
| Package |
Customized Package as you require |
| Usage |
pharmaceutical intermediates, For the production of steroidal hormone drugs and contraceptives, the main raw material. Downstream products acetylene progesterone. |
Dehydroepiandrosterone DHEA Description:
Dehydroepiandrosterone (DHEA) is a natural hormone produced by the adrenal gland, and many bodybuilders are using DHEA to gain a competitive advantage. Recent studies have now shown that supplements enhance lean muscle mass and minimize body fat and compare with natural steroids.
DHEA is used to slow down or reverse aging, improve the thinking ability of the elderly, slow down the progress of Alzheimer’s disease. Athletes and others use DHEA to increase muscle mass, strength and energy. But DHEA’s use is prohibited by the National University Sports Association (NCAA). DHEA is also used by men for erectile dysfunction (ED), as well as healthy women and women who have low levels of certain hormones to improve health and sex behavior.
Dehydroepiandrosterone DHEA Applications:
Usage: pharmaceutical material and intermediates, Steroid hormone.
Anabolic effects include growth of muscle mass and strength, increased bone density and strength, and stimulation of linear growth and bone maturation.
Androgenic effects include maturation of the sex organs, particularly the penis and the formation of the scrotum in the fetus, and after birth (usually at puberty) a deepening of the voice, growth of the beard and axillary hair. Many of these fall into the category of male secondary sex characteristics.
Dehydroepiandrosterone DHEA COA:
| Test Item |
Standard |
Test Results |
| Appearance |
White or alomost white crystalline powder |
white crystalline powder |
| Loss on drying |
<0.5% |
0.24% |
| Optical rotation |
+69~+74 |
73.3 |
| Assay |
97–103% |
99% |
| Free acid |
0.5%max |
0.21% |
| Conclusion |
The aboye product conforms analysis standard |
Conform |
Dehydroepiandrosterone DHEA Uses:
Adequately powered, long-term clinical trials are lacking to support a place in therapy for dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) supplementation (henceforth, jointly referred to as DHEA/S). Reviews of clinical trials found no convincing evidence to support a place in therapy for postmenopausal symptoms in women, in improving cognitive function or physical strength in elderly patients, in hyperlipidemia or insulin resistance, or in schizophrenia or cancer. Some evidence exists to support the use of DHEA/S supplementation in women with diminished ovarian reserves, in subpopulations of elderly women with osteoporosis, and in mild systemic lupus erythematosus.
Dehydroepiandrosterone DHEA Dosing:
Orally administered DHEA has a less than 10% bioavailability and is converted into inactive DHEAS, which can then act as a reservoir for the body to utilize. Daily dosing of DHEA 25 mg has been suggested in postmenopausal women because this dose minimizes the adverse androgenic effects; however, only studies in which at least 50 mg/day were used demonstrated positive outcomes. Dosages used in clinical studies of assisted reproduction were in the range of 50 to 75 mg/day (in divided doses). In adrenal insufficiency, DHEA 50 mg/day for 3 months is considered a replacement dose, while 200 mg/day achieves supraphysiological circulating levels and would thus be considered a pharmacological dose.
Rowe Chen
Sales Manager